The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Omics guided small molecule inhibitor screen for the identification of therapeutic vulnerabilities in metastatic lung adenocarcinoma.
 
Benjamin B. Morris
No Relationships to Disclose
 
Lisa G. Gray
No Relationships to Disclose
 
Ryan D. Gentzler
Honoraria - Rockpointe CME; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Astra Zeneca; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
David Randolph Jones
Leadership - Diffusion Pharmaceuticals
Stock and Other Ownership Interests - Diffusion Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Merck
 
Marty W. Mayo
No Relationships to Disclose